Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Sep;72(3):748–753. doi: 10.1172/JCI111045

Guanine nucleotides modulate the binding affinity of the oligopeptide chemoattractant receptor on human polymorphonuclear leukocytes.

C Koo, R J Lefkowitz, R Snyderman
PMCID: PMC1129239  PMID: 6309908

Abstract

The oligopeptide chemoattractant receptor on human polymorphonuclear leukocyte (PMN) membranes exists in two affinity states. Since guanine nucleotides regulate the binding affinity and transductional activity of several other types of receptors, we examined the effect of nucleotides on the binding of N-formyl-methionyl peptides to their receptors on human PMN membranes. The addition of guanylylimidodiphosphate (0.1 mM), a nonhydrolyzable derivative of guanosine triphosphate (GTP), to PMN membrane preparations reduced the fraction of high-affinity receptors detected in equilibrium binding studies from 21.3 +/- 0.13 to 11.8 +/- 0.05% (P less than 0.03), without altering the binding affinities. Since the total number of receptors remained unchanged, the effect of guanylylimidodiphosphate was to convert a portion of the receptors from the high-affinity state to the low-affinity state. At the maximal concentration of guanine nucleotide tested, approximately 50% of the high-affinity sites were converted to low-affinity sites. The findings obtained by equilibrium binding were supported by kinetic studies since the dissociation of the radiolabeled oligopeptide chemoattractant N-formyl-methionyl-leucyl-[3H]phenylalanine from PMN membranes was accelerated in the presence of guanine nucleotide. The effect of guanine nucleotides was reversed upon washing, indicating that affinity conversion is bidirectional. The guanine nucleotide effects were greatest with nonhydrolyzable derivatives of GTP followed by GTP then guanosine diphosphate. Neither guanosine monophosphate nor any adenine nucleotide tested had an effect on receptor binding. These data suggest a role for guanine nucleotides in the regulation of stimulus-receptor coupling of chemoattractant receptors on human PMN.

Full text

PDF
748

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amrein P. C., Stossel T. P. Prevention of degradation of human polymorphonuclear leukocyte proteins by diisopropylfluorophosphate. Blood. 1980 Sep;56(3):442–447. [PubMed] [Google Scholar]
  2. Bennett N. Light-induced interactions between rhodopsin and the GTP-binding protein. Relation with phosphodiesterase activation. Eur J Biochem. 1982 Mar;123(1):133–139. doi: 10.1111/j.1432-1033.1982.tb06509.x. [DOI] [PubMed] [Google Scholar]
  3. Birdsall N. J., Berrie C. P., Burgen A. S., Hulme E. C. Modulation of the binding properties of muscarinic receptors: evidence for receptor-effector coupling. Adv Biochem Psychopharmacol. 1980;21:107–116. [PubMed] [Google Scholar]
  4. Burgisser E., De Lean A., Lefkowitz R. J. Reciprocal modulation of agonist and antagonist binding to muscarinic cholinergic receptor by guanine nucleotide. Proc Natl Acad Sci U S A. 1982 Mar;79(6):1732–1736. doi: 10.1073/pnas.79.6.1732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. De Lean A., Hancock A. A., Lefkowitz R. J. Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. Mol Pharmacol. 1982 Jan;21(1):5–16. [PubMed] [Google Scholar]
  6. De Lean A., Kilpatrick B. F., Caron M. G. Dopamine receptor of the porcine anterior pituitary gland. Evidence for two affinity states discriminated by both agonists and antagonists. Mol Pharmacol. 1982 Sep;22(2):290–297. [PubMed] [Google Scholar]
  7. Hancock A. A., DeLean A. L., Lefkowitz R. J. Quantitative resolution of beta-adrenergic receptor subtypes by selective ligand binding: application of a computerized model fitting technique. Mol Pharmacol. 1979 Jul;16(1):1–9. [PubMed] [Google Scholar]
  8. Koo C., Lefkowitz R. J., Snyderman R. The oligopeptide chemotactic factor receptor on human polymorphonuclear leukocyte membranes exists in two affinity states. Biochem Biophys Res Commun. 1982 May 31;106(2):442–449. doi: 10.1016/0006-291x(82)91130-5. [DOI] [PubMed] [Google Scholar]
  9. Lad P. M., Welton A. F., Rodbell M. Evidence for distinct guanine nucleotide sites in the regulation of the glucagon receptor and of adenylate cyclase activity. J Biol Chem. 1977 Sep 10;252(17):5942–5946. [PubMed] [Google Scholar]
  10. Mackin W. M., Huang C. K., Becker E. L. The formylpeptide chemotactic receptor on rabbit peritoneal neutrophils. I. Evidence for two binding sites with different affinities. J Immunol. 1982 Oct;129(4):1608–1611. [PubMed] [Google Scholar]
  11. Marx R. S., McCall C. E., Bass D. A. Chemotaxin-induced changes in cyclic adenosine monophosphate levels in human neutrophils. Infect Immun. 1980 Jul;29(1):284–286. doi: 10.1128/iai.29.1.284-286.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Seligmann B., Chused T. M., Gallin J. I. Human neutrophil heterogeneity identified using flow microfluorometry to monitor membrane potential. J Clin Invest. 1981 Nov;68(5):1125–1131. doi: 10.1172/JCI110356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Simchowitz L., Fischbein L. C., Spilberg I., Atkinson J. P. Induction of a transient elevation in intracellular levels of adenosine-3',5'-cyclic monophosphate by chemotactic factors: an early event in human neutrophil activation. J Immunol. 1980 Mar;124(3):1482–1491. [PubMed] [Google Scholar]
  14. Snyderman R., Goetzl E. J. Molecular and cellular mechanisms of leukocyte chemotaxis. Science. 1981 Aug 21;213(4510):830–837. doi: 10.1126/science.6266014. [DOI] [PubMed] [Google Scholar]
  15. Stadel J. M., De Lean A., Lefkowitz R. J. Molecular mechanisms of coupling in hormone receptor-adenylate cyclase systems. Adv Enzymol Relat Areas Mol Biol. 1982;53:1–43. doi: 10.1002/9780470122983.ch1. [DOI] [PubMed] [Google Scholar]
  16. Verghese M. W., Snyderman R. Hormonal activation of adenylate cyclase in macrophage membranes is regulated by guanine nucleotides. J Immunol. 1983 Feb;130(2):869–873. [PubMed] [Google Scholar]
  17. Watanabe A. M., McConnaughey M. M., Strawbridge R. A., Fleming J. W., Jones L. R., Besch H. R., Jr Muscarinic cholinergic receptor modulation of beta-adrenergic receptor affinity for catecholamines. J Biol Chem. 1978 Jul 25;253(14):4833–4836. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES